Featured Research

from universities, journals, and other organizations

Smokers With Heavily Lined Faces Run Five Times The Risk Of Progressive Lung Disease (COPD)

Date:
June 14, 2006
Source:
BMJ Specialty Journals
Summary:
Middle aged smokers, who are heavily lined with wrinkles, are five times as likely to have chronic obstructive pulmonary disease, or COPD for short, suggests research published ahead of print in Thorax. COPD is an umbrella term for a range of progressive chronic lung diseases, such as emphysema and bronchitis, which block the airways and restrict oxygen flow around the body.

Middle aged smokers, who are heavily lined with wrinkles, are five times as likely to have chronic obstructive pulmonary disease, or COPD for short, suggests research published ahead of print in Thorax.

COPD is an umbrella term for a range of progressive chronic lung diseases, such as emphysema and bronchitis, which block the airways and restrict oxygen flow around the body.

In excess of 1 million people are thought to have COPD in the UK, many of whom have not been diagnosed. And the World Health Organization estimates that it will become the third leading cause of death in the world by 2020.

It is well known that smoking causes premature ageing of the skin, and similarly, most cases of COPD are caused by smoking.

But not all smokers go on to develop COPD, and the researchers wanted to know if the extent of facial wrinkling might provide a clue as to a smoker's likelihood of having the disease.

They studied 149 current and former middle aged smokers from 78 families. In all, 68 people had COPD.

More than 80% (124) of the total sample had no or very few facial lines, and 25 had widespread wrinkles.

Forced expiratory volume in 1 second, which measures lung strength, was significantly lower in those with extensive wrinkling than it was in those whose faces were only minimally lined.

And those with lined faces were five times more likely to have COPD than those without, after taking account of age and the number of years as a smoker. Facial wrinkling was also associate with triple the risk of more severe emphysema.


Story Source:

The above story is based on materials provided by BMJ Specialty Journals. Note: Materials may be edited for content and length.


Cite This Page:

BMJ Specialty Journals. "Smokers With Heavily Lined Faces Run Five Times The Risk Of Progressive Lung Disease (COPD)." ScienceDaily. ScienceDaily, 14 June 2006. <www.sciencedaily.com/releases/2006/06/060614120535.htm>.
BMJ Specialty Journals. (2006, June 14). Smokers With Heavily Lined Faces Run Five Times The Risk Of Progressive Lung Disease (COPD). ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/06/060614120535.htm
BMJ Specialty Journals. "Smokers With Heavily Lined Faces Run Five Times The Risk Of Progressive Lung Disease (COPD)." ScienceDaily. www.sciencedaily.com/releases/2006/06/060614120535.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins